Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, on what dates in the last five years NHS England or its predecessor organisations have taken a decision to consult on whether to make Duodopa available for routine use on the NHS (a) internally and (b) externally.

Duodopa has never been routinely commissioned by NHS England.

NHS England assumed responsibility for directly commissioning specialised services in April 2013 and prior to this, responsibility for commissioning specialised services rested with the national NHS Specialised Services and the 10 regional specialised commissioning groups. Details of any consultations and commissioning decisions are not held centrally.